Oric Pharmaceuticals Quarterly Balance Sheet
NASDAQ: ORICHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Oric Pharmaceuticals financial position
As of Jun 30, 2026, Oric Pharmaceuticals reported total assets of $404.7 million, up 16.7% from a year earlier against total liabilities of $23.4 million. Shareholders' equity stood at $381.3 million, or 94.2% of assets. The company held $37.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 13.19, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Oric Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 37.48M | 56.40M | 45.67M | 49.67M | 75.86M | 49.33M | 59.41M | 44.23M | 49.83M | 56.36M | 23.38M | 26.24M |
| Short-Term Investments | 227.28M | 225.54M | 235.82M | 237.47M | 206.65M | 154.39M | 196.55M | 228.14M | 236.57M | 260.42M | 184.80M | 201.06M |
| Total Current Assets | 273.69M | 290.23M | 288.47M | 295.59M | 291.12M | 211.43M | 262.25M | 279.43M | 294.60M | 324.08M | 212.60M | 232.24M |
| Property, Plant & Equipment | 2.24M | 2.15M | 2.42M | 2.56M | 2.76M | 3.02M | 2.92M | 3.09M | 2.88M | 2.80M | 2.86M | 3.06M |
| Long-Term Investments | 122.80M | 137.78M | 110.76M | 125.91M | 45.22M | 20.04M | 0 | 10.00M | 22.13M | 14.69M | 26.85M | 28.87M |
| Total Assets | 404.69M | 436.76M | 408.89M | 431.19M | 346.86M | 242.86M | 274.14M | 302.07M | 328.91M | 350.79M | 252.01M | 274.33M |
| Accounts Payable | 3.87M | 2.90M | 3.82M | 2.90M | 3.13M | 5.16M | 1.55M | 4.25M | 2.31M | 2.99M | 944.00K | 3.74M |
| Total Current Liabilities | 20.76M | 17.77M | 20.42M | 20.18M | 18.05M | 17.62M | 24.85M | 21.25M | 19.54M | 15.21M | 20.46M | 18.94M |
| Total Liabilities | 23.43M | 21.20M | 24.53M | 24.27M | 22.86M | 23.12M | 31.02M | 28.08M | 26.51M | 22.14M | 27.92M | 26.92M |
| Shareholders' Equity | 381.26M | 415.56M | 384.36M | 406.92M | 324.00M | 219.74M | 243.12M | 273.99M | 302.40M | 328.64M | 224.09M | 247.41M |
| Retained Earnings | -769.50M | -728.01M | -692.24M | -661.74M | -629.15M | -592.79M | -562.77M | -526.47M | -491.90M | -459.94M | -434.93M | -406.60M |
| Net Cash (Debt) | 264.76M | 281.93M | 281.49M | 287.14M | 282.51M | 203.72M | 255.96M | 272.37M | 286.41M | 316.78M | 208.19M | 227.30M |
| Shares Outstanding | 103.64M | 103.49M | 98.53M | 97.28M | 86.19M | 71.08M | 71.02M | 70.56M | 67.67M | 67.42M | 54.87M | 54.54M |
This table shows 12 quarterly periods of Oric Pharmaceuticals's balance sheet, from Q2 2026 back to Q3 2023, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ORIC's reporting calendar. What is a balance sheet?